When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNCA - Genocea under pressure on underwhelming neoantigen vaccine data
Genocea Biosciences Inc.
Genocea Biosciences (NASDAQ:GNCA) slumps 20% premarket on increased volume in apparent response to preliminary data from a Phase 1/2a clinical trial evaluating neoantigen vaccine GEN-009, combined with a checkpoint inhibitor (CPI) (either Merck's Keytruda or Bristol Myers Squibb's Opdivo), in patients with solid tumors.
More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move,